Molecular Health provides a cloud-based healthcare decision engine that integrates molecular and medical data into a comprehensive biomedical data warehouse and delivers individualized analysis for evidence-based targeted therapy identification. Its platform interprets vast biomedical information to generate actionable insights aimed at improving clinical decision making and therapy development. The company says it has the first registered medical device of its kind in Europe for personalized cancer medicine. Molecular Health operates with headquarters in Boston, MA and a parent presence in Heidelberg, Germany, and maintains a laboratory and support center in Greater Houston, TX. The company plans to expand commercial infrastructure and drive broader adoption of its solutions to enable personalized treatment and more efficient therapy development. With this financing the company reports total capital raised to be approximately €100 million.

Total raised

$27M

Funding rounds

1

Latest round

Equity

Latest activity

Nov 2015